code | leader | title | start | end |
---|---|---|---|---|
WP1 | CITST | Management, communication and dissemination (CITST) | 1 (2024-06-01) |
36 2027-05-31) |
T1.1 | CITST | Setup of Internal Communication | 1 (2024-06-01) |
3 2024-08-31) |
T1.2 | CITST | Coordination, Administrative and Financial Management | 1 (2024-06-01) |
36 2027-05-31) |
T1.3 | CITST | Communication and dissemination to stakeholders | 4 (2024-09-01) |
36 2027-05-31) |
T1.4 | LS2N | Scientific dissemination | 10 (2025-03-01) |
36 2027-05-31) |
WP2 | WUT | Platform design, development and integration (WUT) | 2 (2024-07-01) |
35 2027-04-30) |
T2.1 | WUT | Platform architecture (users involved) | 2 (2024-07-01) |
4 2024-09-30) |
T2.2 | WUT | Development of platform components (users involved) | 4 (2024-09-01) |
18 2025-11-30) |
T2.3 | CITST | Platform integration and testing (M10-M20) | 10 (2025-03-01) |
20 2026-01-31) |
T2.4 | LS2N | Platform tuning, optimization and validation | 21 (2026-02-01) |
35 2027-04-30) |
WP3 | LS2N | Smart data processing, personal profiles and digital twin model (LS2N) | 4 (2024-09-01) |
35 2027-04-30) |
T3.1 | LS2N | Backend, data security and datasets | 4 (2024-09-01) |
9 2025-02-28) |
T3.2 | LS2N | Development of data mining and analysis tools to extract end-user profiles | 6 (2024-11-01) |
16 2025-09-30) |
T3.3 | MDU | Development of the twin model for the hypertensive patient | 8 (2025-01-01) |
20 2026-01-31) |
T3.4 | LS2N | Validation and refinement in real-life pilots | 21 (2026-02-01) |
35 2027-04-30) |
WP4 | INRCA | End-user classification, recruitment and pilots (INRCA) | 10 (2025-03-01) |
34 2027-03-31) |
T4.1 | INRCA | Understanding and identifying end-users’ challenges and needs | 10 (2025-03-01) |
14 2025-07-31) |
T4.2 | INRCA | End-user classification, selection and recruitment | 14 (2025-07-01) |
20 2026-01-31) |
T4.3 | INRCA | Pilot implementation | 20 (2026-01-01) |
32 2027-01-31) |
T4.4 | JUMC | User feedback and exit strategy | 16 (2025-09-01) |
34 2027-03-31) |
WP5 | EXYS | Ethics, health economics, exploitation and recommendations (EXYS) | 12 (2025-05-01) |
36 2027-05-31) |
T5.1 | JUMC | Ethical and legal compliance | 12 (2025-05-01) |
36 2027-05-31) |
T5.2 | CITST | Health economics | 12 (2025-05-01) |
36 2027-05-31) |
T5.3 | EXYS | Exploitation and IPR | 24 (2026-05-01) |
36 2027-05-31) |
T5.4 | LS2N | Recommendations and knowledge transfer | 30 (2026-11-01) |
36 2027-05-31) |